[Cytosine arabinoside and VM-26 in induction treatment, failures and recurrences of childhood acute lymphoblastic leukemias].
Navajas Gutiérrez
A
A
Hospital Infantil de Cruces, Departamento de Pediatría, Universidad del Pais Vasco, Facultad de Medicina.
Bezanilla Regato
J L
JL
Moya Calderón
E
E
Piñán
M A
MA
D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D012008:Recurrence; D012074:Remission Induction; D012307:Risk Factors; D013713:Teniposide / Q000627:therapeutic use*
D004338:Drug Combinations; D003561:Cytarabine; D013713:Teniposide; D011034:Podophyllotoxin
Citosín arabinósido y VM-26 en el tratamiento de inducción, fracasos y recidivas de las leucemias linfoblásticas aguda infantiles.